SOLICITATION NOTICE
66 -- Upgrade to Dynatek Laboratories brand M6 Heart Valve Accererated Wear Tester
- Notice Date
- 6/29/2015
- Notice Type
- Presolicitation
- NAICS
- 423490
— Other Professional Equipment and Supplies Merchant Wholesalers
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-SOL-1151658
- Archive Date
- 7/28/2015
- Point of Contact
- Howard S. Yablon, Phone: 2404027630
- E-Mail Address
-
howard.yablon@fda.hhs.gov
(howard.yablon@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- The Food and Drug Administration, Office of Acquisition and Grant Services, intends to award a sole source contract to Dynatek Laboratories Inc. for an upgrade to the FDA's existing Dynatek Laboratories Inc. M6 Heart Valve accelerated wear tester. The proposed contract is for supplies or services for which the Government intends to solicit and negotiate with only one source under FAR authority FAR 6.302-1. "Only one responsible source and no other supplies and services with satisfy agency requirements." The Dynatek Laboratories M6 Heart Valve accelerated tester is being used by the FDA to solve the challenging engineering issues associated with percutaneous/trans catheter heart valve development to assess patient safety and improve public health. Upgrading the existing device to the more technically advanced Dynatek Laboratories Inc. DC7000 digital controller will make it possible for a fast, easy, and reliable interface between the FDA's existing M6 Heart Valve accelerated wear testing system and Dynatek Laboratories real-time data acquisition and monitoring system. Dynatek Laboratories Inc. is the sole manufacturer of this upgrade and existing device. It is sold exclusively by Dynatek Laboratories Inc., is only serviced by Dynatek Laboratories Inc. There are no resellers. This notice to intent is not a request for competitive proposals and no solicitation is currently available. However, all responsible sources may submit a capability statement, proposal or quotation within fifteen (15) days of the publication notice, which shall be considered by the agency. Submit such responses to the Food and Drug Administration, via email, to the point of contact, Howard S. Yablon, howard.yablon@fda.hhs.gov.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-SOL-1151658/listing.html)
- Record
- SN03780285-W 20150701/150629235542-9ce5945ed3604cda580ca8b936b30f2d (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |